Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

Real-time PCR test validated using clinical specimens confirmed

positive for Influenza A H1N1 Swine-origin flu virus

MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction (PCR) test to aid in identifying Influenza A H1N1 Swine-origin (H1N1) flu virus ("S-OIV" or "novel H1N1"), also known as the Swine Flu. The Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test is the first laboratory testing service to be introduced by a commercial laboratory to aid in the identification of patients infected with the novel H1N1 virus and differentiate patients infected with other seasonal Influenza A strains. Focus Diagnostics has a track record of being first to market with new laboratory testing services for emerging infectious diseases, such as West Nile Virus, SARS, and chikungunya virus.

"Our new laboratory test will be an important tool to help health care professionals and public health authorities identify infected patients more quickly, promoting earlier diagnosis and treatment," said Jon R. Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "This capability could be particularly important if the novel H1N1 virus continues to spread in the U.S. or re-emerges this fall or winter. Public health officials in the U.S. have done an exceptional job of managing the current Influenza emergency, and we continue to work closely with them to assist their preparedness efforts."

Focus Diagnostics validated its new Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test using clinical specimens submitt
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 MiMedx Group, Inc. (NASDAQ: ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of ... Chief Scientific Officer, will present at the Stem Cell ... Tuesday, October 7, 2014, at 5:00PM Pacific Daylight Time. ...
(Date:9/30/2014)... 30, 2014 STUDY OBJECTIVES The ... to provide an overview of the current and ... drugs/therapeutics. The key objective is to present a ... as an important tool in the treatment of ... future strategies within the protein therapeutics market, which ...
(Date:9/30/2014)... -- Decision Resources Group finds that the markets for peripheral ... Russia , India ... see robust expansion as these economies expand and as ... revenues will be somewhat impeded by poor distribution of ... and demand for low-cost products, the market will ultimately ...
Breaking Medicine Technology:MiMedx to Present at the Stem Cell Meeting on the Mesa 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3
... Inc. (NYSE: BMR ) announced today the ... (NASDAQ: DEPO ) at its Pacific Research ... company, leased approximately 60,000 square feet of space at ... Research Center campus. Commenting on their relocation ...
... Med-Tek a developer of Healthcare Technology Networks ("HTN") designed ... constituents today announces the launch of its proprietary Opioid ... United States Bone & Joint Decade ... individuals suffering from musculoskeletal disease filled 1.6 billion prescriptions. ...
Cached Medicine Technology:New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 2New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
(Date:10/1/2014)... 1, 2014) Despite a policy focus on ... disabilities, this vulnerable population continues to have significant ... The Journal of the American Dental Association , ... Tufts University School of Dental Medicine report on ... at-home oral care provided by caregivers to adults ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog post ... for vulnerable family members. , Life insurance plans provide ... the family should always carry a life insurance policy ... rest of the family. , Clients can choose ... from temporary coverage or from a permanent policy. No ...
(Date:10/1/2014)... Oregon (PRWEB) October 01, 2014 Phoseon ... solutions , continues to expand the business worldwide. This ... along with additional capacity for manufacturing efforts. The company ... the last five years and expects this growth to ... LED curing technology gains worldwide adoption. , “We ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests that ... depression might also be hard-wired to gain weight when ... disease. , An estimated 13 percent of people, all ... and knowing this could help them reduce heart disease ... and stress management. , "Genetic susceptibility, psychosocial stress and ...
(Date:10/1/2014)... 2014 Diet Doc understands that many of ... weight and their dieting attempts could be easily sabotaged by ... hormone diet treatments into their programs as a way ... fast and effective weight loss results, it also allows patients ... to maintain their weight for the future. , Earlier versions ...
Breaking Medicine News(10 mins):Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... are reluctant to go in for research collaborations though the ... than in many Southeast Asian nations. ... a great reluctance towards online education in this country, London ... ,"In India, the emphasis is still on the teacher ...
... the incidence of asthma increases by 50 percent,// as ... meta-analysis of seven studies on severe asthma involving 333,102 ... 2007 of the American Journal of Respiratory and Critical ... ,E. Rand Sutherland, M.D., M.P.H., of the ...
... more easily when they figure out the words' meaning for ... ,Meredith Brinster, an undergraduate student in the John ... found that learning words by inference is more powerful for ... ,"One of the things that is particularly exciting about the ...
... health insurance through the state children’s health insurance ... racial disparities are eliminated and more preventive care ... more counseling from their health care providers about ... issues that impact their long-term health. ...
... continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous ... of sleep disturbance in chronic pain, according to a ... journal SLEEP., ,The study, conducted by Michael T. ... on 32 healthy females, who were studied polysomnographically for ...
... Exposure to a type of bacteria found in soil boosts ... people who are depressed and prone to infection, says a ... Bristol University treated lung cancer patients with the bacteria, named ... life, reported the online edition of BBC News. ...
Cached Medicine News:Health News:LondonMet Keen on Widening Research Collaborations With India 2Health News:LondonMet Keen on Widening Research Collaborations With India 3Health News:Asthma Incidence Shows a 50 Percent Increase in Fat People 2Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Teens Get Needed Access to Care With State Health Insurance 2Health News:Teens Get Needed Access to Care With State Health Insurance 3Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... Portex® medication nebulizers offer a spill-proof ... up to a 45° angle. All medical ... ,A wide variety of configurations are available., ... latex-free. , ,Portex® medication nebulizers feature ...
... inhalers., ,ACE ensures prompt, effective delivery ... versatile design allows it to be used ... an endotracheal airway or resuscitation bag and ... be used in conjunction with an incentive ...
... can be held at angles up to 45° ... in spill column, finger grooves for a non-slip ... 7 feet of regular oxygen tubing. The ... size and sustain optimum mist concentration at every ...
Medicine Products: